Display Post Content

SNAC introduce latest experience in Quantitative Neuroimaging Analysis at GTC Digital

The director of operations in Sydney Neuroimaging Analysis Centre, Tim Wang , is honoured to be one of the featured speakers in healthcare & life science sessions at GTC Digital (GTC 2020) , in which he provides the online presentation: “Accelerate Quantitative Clinical Neuroimaging Analysis with AI: Steps Toward Personalised Disease Progression Monitoring in Clinical Neurology”.

 

GTC2.png

GTC (GPU Technology Conference), is an annual gathering hosted by NVIDIA. GTC attracts professionals in the graphics processing unit (GPU) to share experiences in deep learning, cybersecurity, autonomous machines, intelligent video analysis, healthcare etc. Amidst the outbreak of COVID-19, an online conference - GTC Digital has been facilitated, which covers a range of training, research, insights and lead to “direct access to the brilliant minds of NVIDIA GPU Technology Conference 2020”.

 

GTC2.png

Dr. Tim Wang will share SNAC’s experience in using quantitative neuroimaging analysis to assist extracting further clinical data in diagnostic imaging. By providing a fine scale measure on monitoring brain-tissue changes in the progression of neurodegenerative disease, and following the quality assurance on analysis contributed by radiologists- then implementing deep learning to assign complex analysis into automation, SNAC is able to carry out its goal of improving efficiency and accuracy in modern clinical practice.

 

For more details please go to the following link:   

 https://www.nvidia.com/en-us/gtc/session-catalog/?search=21421#/

For more information please contact:   

Email: info@snac.com.au

Web: snac.com.au

SNAC Scientists attend AIMed Australia 2019

AIMed.png

Sydney Neuroimaging Analysis Centre attended AIMed 2019 on 12-13 November in Sydney. Our AI Scientists acknowledged latest findings and experiences of AI in the medical sphere, especially within radiology and neurology.

 

AIMed, as the world’s leading event on Artificial Intelligence in Medicine and Healthcare, has a mission statement to “define AI-enabled solutions and create an efficient workplace, with patient outcomes at its core”. It aims to utilise advanced technology to assist medical professionals in enhancing their work. Originated in the US, AIMed now has become an annual multi-disciplinary gathering for AI and medical professionals to trace the latest AI concepts and applications in medicine, in Europe, Asia and Australia.

 

“AIMed has been yearning to be in Australia as some of the World’s best minds in informatics and intelligence in biomedicine are in that region. In order to be excellent at AI in medicine and healthcare, we need to learn about each country’s health system, AI landscape, and how they solve problems using AI. We very much look forward to this exciting opportunity to learn from each other”. AIMed Chairman and Founder, Chief Intelligence and Innovation Officer of Children’s Hospital of Orange County (CHOC) Dr. Anthony Chang.

 

revolution.png

At SNAC, AI scientists are also passionate about the use of data and algorithms to make a difference on current evidence-based medical imaging and clinical use. We are aware of not only the huge impact Artificial Intelligence is able to provide on fast and accurate automatic diagnosis using medical imaging, but also the inherent challenges needed to be overcome. As well as pushing the precision and recall of AI models to a satisfactory level, our AI scientists also contribute to enhancing present medical imaging analysis tools by using deep learning methods, including automatic brain extraction and automatic lesion implanting.

For more information please contact:   

Email: info@snac.com.au

Web: snac.com.au

Sydney Neuroimaging Analysis Centre showcased its Central Readings Services at ECTRIMS 2019

EctrimsTeam.png

During 11-13 September 2019, the Clinical Trial Team from SNAC , demonstrated its multimodal turnkey central reading solution for Phase 2 Remyelination Clinical Trials, at ECTRIMS 2019 in Stockholm, Sweden.

 

ECTRIMS- European Committee for Treatment and Research in Multiple Sclerosis (MS), started in Europe and has served as world’s largest professional organization for acknowledging and treating multiple sclerosis. ECTRIMS creates and collaborates opportunities for researchers and clinicians worldwide to support clinical research and improve outcomes in MS.

 

Based on its strong neurology and neuroimaging connections with University of Sydney, neuroimaging services provided by SNAC is complemented by its research power, in which it also derives its educational and training strength on MRI-based outcomes interpretation in Morden clinical trialsBased on its strong neurology and neuroimaging connections with University of Sydney, neuroimaging services provided by SNAC is complemented by its research power, in which it also derives its educational and training strength on MRI-based outcomes interpretation in Morden clinical trials.

 

At ECTRIMS 2019, a diverse team of neurologists, clinical trial professionals and neuroimaging specialist from SNAC and their collaborators shared their latest perspectives on MS in clinical trial practice and neuroimaging analysis. Our showcase has highlighted SNAC’s unique approach to providing accurate measurements of remyelination in both acute and chronic MS lesions, which use visual systems as a platform, and facilitate testing of emerging remyelinating therapies.

Ectrims.png

For more information please contact:   

Email: info@snac.com.au

Web: snac.com.au

NVIDIA Clara - Intelligent Compute Engine for Healthcare and Life Sciences

original.20190718-025812.jpeg

 

POWERING THE NEXT GENERATION OF HEALTHCARE

Deep Learning research in Medical Imaging is booming with more efficient and improved approaches being developed to enable AI-assisted workflows.  Today, most of this AI research is being done in isolation and with limited datasets which may lead to overly simplified models. Even when a fully validated model is available, it is a challenge to deploy the algorithm in a local environment. With the latest release of Clara AI for Medical Imaging now data scientists, researchers and software developers have the necessary tools, APIs and development framework to train and deploy AI workflows.

Clara Train and Deploy SDKs provide Data Scientists and Radiologists with the tools to build, manage, and deploy AI workflows in medical imaging. Clara Train SDK includes APIs to add AI Assisted annotation to any medical viewer and provides a training framework optimized to train AI models for Medical Imaging. Clara Deploy SDK provides a container based development & deployment framework for building AI accelerated medical imaging workflows that can interface in a hospital infrastructure.

NVIDIA is co-hosting a free full-day workshop with the Sydney Neuroimaging Analysis Centre and the Brain and Mind Centre on using artificial intelligence tools for medical imaging research and clinical tasks. This workshop provides the perfect opportunity for students, scientists, and clinicians who are new to artificial intelligence and would like to start harnessing its power for diagnosing and treating various diseases. Examples include AI image processing and automatic lesion delineation for the brain, lungs, liver, prostate, and other organs.

Registration is now OPEN via the following link:

https://nvidia_clara.eventbrite.com/

Location: Room 502 Brain and Mind Centre, 94 Mallett Street Camperdown, NSW 2050

Time: Wed, August 28, 2019        8:30AM – 4:00 PM AEST

Free morning tea, lunch, and afternoon tea are provided.  

 

logo_transparent_blue.png       sm-Nvidia_image_logo.svg.png         The-University-of-Sydney-Brain-and-Mind-Centre.png    

Sydney Neuroimaging Analysis Centre (SNAC) secures A$2.36 million Australian Government CRC-P Grant to transform Clinical Neuroimaging with AI.

 

Deep_learning.png

 

·      SNAC is the lead participant in a successful CRC-P grant application: AI: new smarts for the medical imaging industry

·      The CRC-P grant provides A$2.36 million funding, with additional matched cash and in-kind participant funding.

·      Together with national imaging provider I-MED Radiology Network (I-MED) and the University of Sydney’s Brain and Mind Centre, SNAC will develop, implement and commercialise clinically meaningful AI algorithms in the clinical and clinical trials neuroimaging space.

 

Sydney Neuroimaging Analysis Centre (SNAC) is pleased to announce its recent success in securing support for its Artificial Intelligence in Neuroimaging project through the Australian Government’s Cooperative Research Centres (CRC) Programme.  As the lead participant, SNAC has been awarded a A$2.36 million grant, with matched cash and in-kind funding from the project participants, including SNAC, I-MED and the University of Sydney’s Brain and Mind Centre.

 

The Cooperative Research Centres (CRC) Programme is administered by AusIndustry, a division within the Department of Industry, Innovation and Science. The CRC Programme is a competitive, merit based grant programme that supports industry-led and outcome-focused collaborative research partnerships between industry, researchers and the community.

 

Dr Tim Wang PhD, Director of Operations for SNAC, said “The provision of CRC-P funding will significantly accelerate the expansion of SNAC’s neuro-imaging biomarker portfolio, enhance clinical trials of emerging therapies for neurological disorders such as multiple sclerosis and, through our partnership with I-MED, transform diagnostic neuroimaging”

 

“Partnership with the Computational Neuroscience Team at the University of Sydney’s Brain and Mind Centre, led by neurologist Professor Michael Barnett and AI expert Professor Dacheng Tao, is a pivotal strength of the project”.

 

SNAC specialises in the provision of regulatory-compliant neuroimaging analysis to the pharmaceutical industry and in particular the development of novel neuroimaging biomarkers and their implementation in Phase 2-4 clinical trials.  SNAC also works closely with academics in imaging science and clinical medicine to further research into neurological disease.

 

For more information please contact:   

Dr Tim Wang, Director of Operations

Email: tim@snac.com.au

Web: snac.com.au